Charles Schwab Investment Management Inc. lifted its holdings in shares of Varex Imaging (NASDAQ:VREX - Free Report) by 10.8% during the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 437,667 shares of the company's stock after purchasing an additional 42,661 shares during the quarter. Charles Schwab Investment Management Inc. owned 1.06% of Varex Imaging worth $5,077,000 at the end of the most recent quarter.
Other hedge funds also recently modified their holdings of the company. Assenagon Asset Management S.A. raised its position in shares of Varex Imaging by 6.5% during the first quarter. Assenagon Asset Management S.A. now owns 113,573 shares of the company's stock worth $1,317,000 after purchasing an additional 6,953 shares during the period. SG Americas Securities LLC bought a new stake in shares of Varex Imaging in the first quarter valued at about $1,092,000. GAMMA Investing LLC lifted its holdings in shares of Varex Imaging by 960.3% in the first quarter. GAMMA Investing LLC now owns 16,170 shares of the company's stock valued at $188,000 after purchasing an additional 14,645 shares in the last quarter. Wealth Enhancement Advisory Services LLC bought a new stake in shares of Varex Imaging in the fourth quarter valued at about $190,000. Finally, Deutsche Bank AG lifted its holdings in shares of Varex Imaging by 84.5% in the fourth quarter. Deutsche Bank AG now owns 31,463 shares of the company's stock valued at $459,000 after purchasing an additional 14,407 shares in the last quarter.
Varex Imaging Stock Up 0.7%
Shares of NASDAQ:VREX traded up $0.08 during midday trading on Monday, reaching $11.55. The company had a trading volume of 151,509 shares, compared to its average volume of 545,010. The company has a quick ratio of 1.82, a current ratio of 3.51 and a debt-to-equity ratio of 0.78. The business's 50 day moving average price is $8.91 and its 200 day moving average price is $9.42. The stock has a market cap of $479.33 million, a PE ratio of -3.60 and a beta of 0.87. Varex Imaging has a 1-year low of $6.76 and a 1-year high of $16.93.
Varex Imaging (NASDAQ:VREX - Get Free Report) last released its earnings results on Thursday, August 7th. The company reported $0.18 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.04 by $0.14. The business had revenue of $203.00 million for the quarter, compared to the consensus estimate of $190.32 million. Varex Imaging had a positive return on equity of 5.54% and a negative net margin of 16.13%. Varex Imaging has set its Q4 2025 guidance at 0.100-0.300 EPS. Research analysts forecast that Varex Imaging will post 0.53 EPS for the current fiscal year.
Wall Street Analyst Weigh In
A number of analysts have recently commented on VREX shares. B. Riley restated a "buy" rating and issued a $16.00 price target (up from $12.00) on shares of Varex Imaging in a report on Friday, August 8th. Wall Street Zen lowered Varex Imaging from a "strong-buy" rating to a "buy" rating in a report on Saturday, August 9th. Two equities research analysts have rated the stock with a Buy rating, Based on data from MarketBeat.com, the company presently has an average rating of "Buy" and an average price target of $19.50.
Read Our Latest Research Report on VREX
Varex Imaging Company Profile
(
Free Report)
Varex Imaging Corporation designs, manufactures, and sells X-ray imaging components. The company operates through two segments, Medical and Industrial. The Medical segment designs, manufactures, sells, and services X-ray imaging components, comprising X-ray tubes, digital detectors and accessories, ionization chambers, high voltage connectors, image-processing software and workstations, 3D reconstruction software, computer-aided diagnostic software, collimators, automatic exposure control devices, generators, and heat exchangers.
Featured Articles

Before you consider VAREX IMAGING, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and VAREX IMAGING wasn't on the list.
While VAREX IMAGING currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.